The world’s largest healthcare plan has been launched by Indian Prime Minister Narendra Modi, providing free or subsidized coverage for the poorest 40% of India’s population.
Officially known as the Ayushman Bharat Scheme, the plan has been dubbed, with a certain degree of inevitability, ‘Modicare’.
It will see some half a billion Indians gain access to pharmaceuticals and other healthcare products and services. The 100 million poorest families will be eligible to receive nearly $7,000 worth of health insurance every year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze